Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

Blood Transfusion

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Probing mental representations of space through sketch mapping: a scoping review.

Cognitive research: principles and implications·2025

Same author

Effect of Plyometric Jump Training on Skeletal Muscle Hypertrophy in Healthy Individuals: A Systematic Review With Multilevel Meta-Analysis.

Frontiers in physiology·2022

Same author

Fish, genes and genomes: contributions to ecology, evolution and management.

Journal of fish biology·2016

Same author

Complete Genome Sequence of Alkaliphilus metalliredigens Strain QYMF, an Alkaliphilic and Metal-Reducing Bacterium Isolated from Borax-Contaminated Leachate Ponds.

Genome announcements·2016

Same author

Subtle genetic population structure in Pacific halibut Hippoglossus stenolepis.

Journal of fish biology·2016

Same author

It's a bear market: evolutionary and ecological effects of predation on two wild sockeye salmon populations.

Heredity·2016

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

[Introduction of platelet additive solution in platelet concentrates: towards a decrease of blood transfusion

D Rebibo¹, M Simonet, L Hauser

¹Direction médicale et scientifique, pôle vigilances, établissement français du sang, La-Plaine-Saint-Denis, France. danielle.rebibo@efs.sante.fr

Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine

|October 22, 2008

Summary

Additive solutions in platelet concentrates (PCs) significantly reduce allergic transfusion reactions. This study found fewer adverse reactions overall when using PCs with additive solutions, improving patient safety.

More Related Videos

Routine Screening Method for Microparticles in Platelet Transfusions

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

Related Experiment Videos

Last Updated: Jun 28, 2026

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination

Published on: August 24, 2015

Routine Screening Method for Microparticles in Platelet Transfusions

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

Area of Science:

Transfusion Medicine
Hematology
Blood Product Safety

Context:

Platelet concentrates (PCs) are crucial for managing hemorrhagic risk in thrombocytopenia.
Additive solutions have been incorporated into PCs over the past five years.
These solutions aim to mitigate plasma-intolerance reactions and improve transfusion outcomes.

Purpose:

To evaluate the frequency of adverse reactions in recipients of PCs with and without additive solutions.
To compare the incidence of specific adverse reaction categories: allergies, febrile non-hemolytic reactions (FNHR), and unknown reactions.

Summary:

Analysis of three years of transfusion data in France revealed a significant decrease in allergic reactions with the introduction of additive solutions in PCs.
Overall adverse reactions in recipients were reduced when using PCs with additive solutions, with notable exceptions for apheresis platelet concentrates.
The study found no significant or opposing trends for FNHR and unknown adverse reaction categories.

Impact:

Confirms the efficacy of additive solutions in reducing specific transfusion reactions, particularly allergies.
Supports the routine use of additive solutions in platelet concentrate preparation to enhance patient safety.
Provides evidence-based data for transfusion guidelines and clinical practice regarding platelet additive solutions.